No profile data available.
Tiziana Life Sciences Ltd (TLSA) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in London, United Kingdom, with about 10 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$18.43 million. Its market capitalization was $151.44 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally.
Tiziana Life Sciences reported $0 in revenue for fiscal year 2025.
$151.44 million as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Bicycle Therapeutics plc (BCYC), ProQR Therapeutics N.v. (PRQR), Protara Therapeutics, Inc. (TARA), Korro Bio, Inc. (KRRO).